RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression

Journal of Cellular Physiology

Volumn 226, Issue 9, 2011, Pages 2360-2369

  Yi, Mei ^a,b   Yang, Jianbo ^c   Chen, Xiang ^a   Li, Ji ^a   Li, Xiayu ^b,d   Wang, Li ^b   Tan, Yixin ^e   Xiong, Wei ^b   Zhou, Ming ^b   Mccarthy, James B ^c   Li, Guiyuan ^b   Xiang, Bo ^a,b   Xie, Hongfu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; EUKARYOTIC INITIATION FACTOR-4E; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE KINASE 5; MELANOMA; MICE; MITOCHONDRIA; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; S PHASE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 79958761658     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22568     Document Type: Article

References (25)

1. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S. 2001. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691.
2. Chow LSN, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP. 2004. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 109: 839-847.
3. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. 2000. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315-319.
4. Goto Y, Ferrone S, Arigami T, Kitago M, Tanemura A, Sunami E, Nguyen SL, Turner RR, Morton DL, Hoon DSB. 2008. Human high molecular weight-melanoma-associated antigen: Utility for detection of metastatic melanoma in sentinel lymph nodes. Clin Cancer Res 14: 3401.
5. Hatai T, Matsuzawa A, Inoshita S, Mochida Y, Kuroda T, Sakamaki K, Kuida K, Yonehara S, Ichijo H, Takeda K. 2000. Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J Biol Chem 275: 26576.
6. Hay N. 2005. The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8: 179-1183.
7. Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev 18: 1926.
8. Hoon DSB, Spugnardi M, Kuo C, Huang SK, Morton DL, Taback B. 2004. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 23: 4014-4022.
9. Houchens DP, Ovejera AA, Barker AD. 1978. The therapy of human tumors in athymic (nude) mice. In: Houchens DP, Ovejera AA (eds) Proceedings of the Symposium on the Use of Athymic (nude) Mice in Cancer Research. New York: Gustav Fischer. pp 267-280.
10. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90.
11. Marini A, Mirmohammadsadegh A, Nambiar S, Gustrau A, Ruzicka T, Hengge UR. 2005. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma. J Invest Dermatol 126: 422-431.
12. Miller AJ, Mihm MC, Jr. 2006. Melanoma. N Engl J Med 355: 51.
13. Rastetter M, Schagdarsurengin U, Lahtz C, Fiedler E, Marsch WC, Dammann R, Helmbold P. 2007. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma. Histol Histopathol 22: 1005.
14. Reifenberger J, Knobbe CB, Sterzinger AA, Blaschke B, Schulte KW, Ruzicka T, Reifenberger G. 2004. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. Int J Cancer 109: 377-384.
15. Sekimukai D, Honda S, Negi A. 2009. RNA interference for apoptosis signal-regulating kinase-1 (ASK-1) rescues photoreceptor death in the rd1 mouse. Mol Vis 1764-1773.
16. Spugnardi M, Tommasi S, Dammann R, Pfeifer GP, Hoon DSB. 2003. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Cancer Res 63: 1639.
17. Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MFG, Morton DL, Hoon DSB. 2009. CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 15: 1801.
18. Tellez CS, Shen L, Estécio MRH, Jelinek J, Gershenwald JE, Issa JPJ. 2009. CpG island methylation profiling in human melanoma cell lines. Melanoma Res 19: 146.
19. Thaler S, Hahnel PS, Schad A, Dammann R, Schuler M. 2009. RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res 69: 1748.
20. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H. 2001. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2: 222-228.
21. Whang YM, Kim YH, Kim JS, Yoo YD. 2005. RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res 65: 3682.
22. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. 1997. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129.
23. Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, Li XL, Luo XM, Wu MH, Yang YX, Huang C. 2007. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 38: 120-1133.
24. Zhang R, Luo D, Miao R, Bai L, Ge Q, Sessa WC, Min W. 2005. Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. Oncogene 24: 3954-3963.
25. Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M, Tan Y, Yi W, Xiao L, Li X, Huang C. 2008. Lactotransferrin: A candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer 123: 2065-2072.